Literature DB >> 12781618

Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma.

D Wisser1, J Steffes.   

Abstract

This case report describes the successful wound management of a 19-year-old patient with 76% of his body surface burnt. Due to the severity of the burns and the limited availability of native skin, 63% of the body surface were covered with Integra, a dermis equivalent. This material has been developed for the reconstruction of dermal structures and is designed as a bilayer. It consists of a modified, bovine collagen matrix and a silastic membrane facing toward the body surface. After vascularization of Integra, the epidermal skin replacement was created in a second step. In four different therapy procedures autologous, cultivated keratinocytes were combined with autologous fibroblast suspensions of various concentration and split-thickness skin as a 1:6 mesh graft. Rapid and largely complication-free wound healing could be achieved despite the limited availability of native skin. A correlation could be observed between the time of complete wound closure and the number of fibroblasts applied. The patient was monitored over a period of 1 year and showed good functional and cosmetic results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781618     DOI: 10.1016/s0305-4179(03)00013-5

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  16 in total

Review 1.  A general overview of burn care.

Authors:  Michel H E Hermans
Journal:  Int Wound J       Date:  2005-09       Impact factor: 3.315

2.  In vitro comparison of six different matrix systems for the cultivation of human chondrocytes.

Authors:  Karsten Gavénis; Bernhard Schmidt-Rohlfing; Ralf Mueller-Rath; Stefan Andereya; Ulrich Schneider
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 May-Jun       Impact factor: 2.416

3.  Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature.

Authors:  Xiaofang Chen; Anna S Aledia; Cyrus M Ghajar; Craig K Griffith; Andrew J Putnam; Christopher C W Hughes; Steven C George
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

4.  Porcine wound healing in full-thickness skin defects using Integra™ with and without fibrin glue with keratinocytes.

Authors:  Mark M Melendez; Rodrigo R Martinez; Alexander B Dagum; Steve A McClain; Marcia Simon; Joseph Sobanko; Thomas Zimmerman; Meredith Wetterau; Douglas Muller; Xiaoti Xu; Adam J Singer; Balvantray Arora
Journal:  Can J Plast Surg       Date:  2008

5.  Tissue-engineered skin: bottleneck or breakthrough.

Authors:  Sha Huang; Xiaobing Fu
Journal:  Int J Burns Trauma       Date:  2011-08-25

6.  An Open-Label Study of Low-Level Laser Therapy Followed by Autologous Fibroblast Transplantation for Healing Grade 3 Burn Wounds in Diabetic Patients.

Authors:  Mohammad Ali Nilforoushzadeh; Nooshafarin Kazemikhoo; Soheila Mokmeli; Sona Zare; Mostafa Dahmardehei; Reza Vaghar Doost; Mahnoush Momeni; Fereshteh Ansari
Journal:  J Lasers Med Sci       Date:  2019-12-01

7.  Full-Thickness Thermal Injury Delays Wound Closure in a Murine Model.

Authors:  Jesse C Wu; Lloyd F Rose; Robert J Christy; Kai P Leung; Rodney K Chan
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-02-01       Impact factor: 4.730

Review 8.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

9.  Porcine collagen crosslinking, degradation and its capability for fibroblast adhesion and proliferation.

Authors:  Marcus L Jarman-Smith; Tulin Bodamyali; Cliff Stevens; John A Howell; Michael Horrocks; Julian B Chaudhuri
Journal:  J Mater Sci Mater Med       Date:  2004-08       Impact factor: 3.896

10.  Dermal regenerative matrix use in burn patients: A systematic review.

Authors:  Katie E Hicks; Minh Nq Huynh; Marc Jeschke; Claudia Malic
Journal:  J Plast Reconstr Aesthet Surg       Date:  2019-08-08       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.